Brokers Ratings on: Cogentix Medical, Inc. (NASDAQ:CGNT)


Cogentix Medical, Inc. (NASDAQ:CGNT) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.

Cogentix Medical, Inc. (NASDAQ:CGNT) gained 0.39 Percent and closed its previous trading session at $3.84. The stock traded with the average Volume of 131.3 Million at the end of last session.

Cogentix Medical, Inc. (NASDAQ:CGNT) has the Market Capitalization of 237.04 Million. The Stock has its 52-week High of $3.89 and 52-Week Low of $1.55 and it touched its 52-week high on 03/12/18 and 52-Week Low on 05/17/17.

The analyst predicted that the company could provide an EPS of $-0.01/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.01/share which shows an Earnings Surprise of 100 Percent.

Sell side analysts plays vital role in buying and selling a stock where 2 analysts rated Cogentix Medical, Inc. (NASDAQ:CGNT) as Buy, 0 analysts given Outperform signal, 0 reported Hold, and 0 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 25.8% where SMA50 and SMA200 are 30.25% and 51.8% respectively.

The company shows its Return on Assets (ROA) value of -27%. The Return on Equity (ROE) value stands at -30.9%. While it’s Return on Investment (ROI) value is -3.1%.

Cogentix Medical, Inc. (NASDAQ:CGNT) currently has a Weekly Volatility of 3.59% percent while its Monthly Volatility is at 5.03% percent. While talking about Performance of the Stock, Cogentix Medical, Inc. currently has a Weekly performance of 19.1%, monthly performance percentage is 39.45 percent, Quarterly performance is 30 percent, 6 months performance shows a percent value of 54.02% and Yearly Performance is 97.68 percent.

Company Profile:

Cogentix Medical, Inc. is a medical device company which designs, develops, manufactures and markets proprietary technologies serving the urology market. The company’s primary product consists of Urgent(R) PC Neuromodulation System and EndoSheath System. It operates primarily in Orangeburg, New York, The Netherlands and the United Kingdom. Cogentix Medical, Inc., formerly known as Vision-Sciences Inc., is headquartered in Orangeburg, New York.